<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="retraction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fncel.2023.1355800</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular Neuroscience</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: 1, 25-D<sub>3</sub> protects from cerebral ischemia by maintaining BBB permeability via PPAR-&#x003B3; activation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/228891/overview"/>
</contrib>
</contrib-group> <author-notes>
<fn fn-type="edited-by"><p>Approved by: Dirk M. Hermann, University of Duisburg-Essen, Germany</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Frontiers Editorial Office <email>research.integrity&#x00040;frontiersin.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>17</volume>
<elocation-id>1355800</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front Cell Neurosci" journal-id-type="nlm-ta" vol="12" page="480" xlink:href="10.3389/fncel.2018.00480" ext-link-type="doi">A Retraction of the Original Research Article <article-title>1, 25-D<sub>3</sub> protects from cerebral ischemia by maintaining BBB permeability via PPAR-&#x003B3; activation</article-title> by Guo, T., Wang, Y., Guo, Y., Wu, S., Chen, W., Liu, N., Wang, Y., and Geng, D. (2018). <italic>Front. Cell. Neurosci</italic>. 12:480. doi: <object-id>10.3389/fncel.2018.00480</object-id></related-article>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="323"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cellular Neuropathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The journal retracts the 17th December 2018 article cited above.</p>
<p>Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers&#x00027; policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.</p>
<p>This retraction was approved by the Chief Editors of Frontiers in Cellular Neuroscience and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.</p>
</body>
</article>